title: [Thinking about evaluation of proprietary Chinese medicines containing toxic herbs during switch process of non-prescription drugs].
abstract: To enhance the scientific and fair evaluation about proprietary Chinese medicines containing toxic herbs during the switch process of non-prescription drugs, and to ensure those medicines to be used safely by the public in their self-medication. Combined with current research status of toxic herbs, the experience and knowledge accumulated in the practical work of selection and switch of OTC Chinese medicines for years, thinking about the feasible standards about evaluation and management of proprietary Chinese medicines containing toxic herbs at this stage. Initially established ideas and methods about evaluation of proprietary Chinese medicines containing toxic herbs during the switch process of non-prescription drugs. Basically solved the main problem currently faced by toxic herbs during the OTC switch process of proprietary Chinese medicines, effectively promoted the work on OTC switch, and had the important significance in making consumers use non-prescription drugs conveniently and safely.
authors: Center for Drug Reevaluation, SFDA, Beijing 100045, China. xiadongsheng@cdr.gov.cn
authors: Dongsheng
authors: D
authors: Xia
authors: Gang
authors: G
authors: Cheng
authors: Xinling
authors: X
authors: Li
authors: Jieming
authors: J
authors: Zhou
authors: Aili
authors: A
authors: Xiao
authors: Chengxu
authors: C
authors: Zhang
authors: Xiaoxi
authors: X
authors: Du
mesh_terms: D006801:Humans; D008516:Medicine, Chinese Traditional / Q000009:adverse effects* / Q000379:methods; D004366:Nonprescription Drugs / Q000009:adverse effects* / Q000145:classification*; D010947:Plants, Toxic / Q000009:adverse effects* / Q000145:classification*; D011786:Quality Control; D012106:Research / Q000706:statistics & numerical data
chemical_list: D004366:Nonprescription Drugs